Levetiracetam Arrow

Levetiracetam, the active ingredient in Levetiracetam Arrow, is an antiepileptic presented as an intravenous solution for intravenous use. It treats various seizure types in patients requiring hospital‑based therapy. GNH USA supplies Levetiracetam Arrow as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Levetiracetam Arrow as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Levetiracetam Arrow is an antiepileptic medication that acts on neuronal excitability to control seizures. - Epilepsy: Provides broad seizure control across multiple seizure types. - Partial seizures: Reduces frequency and severity of focal seizures. - Generalized tonic‑clonic seizures: Helps prevent the occurrence of generalized convulsive episodes. - Myoclotic seizures: Diminishes the rapid, brief muscle jerks characteristic of myoclonic seizures.

Levetiracetam Arrow may cause a range of adverse reactions.

Common Side Effects: - Dizziness. - Fatigue. - Headache. - Nausea. - Irritability.

Serious or Rare Side Effects: - Severe skin reactions such as Stevens‑Johnson syndrome. - Hematologic abnormalities like neutropenia. - Hepatic dysfunction. - Suicidal thoughts or behaviors. - Acute hypersensitivity reactions. - Respiratory depression 

Levetiracetam Arrow should be administered ฏ   \